Fresh Buy Signal on Phio Pharmaceuticals
Phio Pharmaceuticals stock gains 8.3%, opening a fresh Buy signal
Our view last week
Phio Pharmaceuticals' Sell signal has been running for 16 weeks, and this week the data finally tell one consistent story: the stock gains 4.8% and buyers make up more than 60% of trading, ending the run of contradictory weeks seen lately. Phio Pharmaceuticals stock stays boxed between the 1.07 area and the 1.11 area, but weekly RSI climbs toward 47 and the MACD keeps improving: the downward push is fading.
This week's summary
After sixteen weeks under a Sell signal, Phio Pharmaceuticals turns: the week closes up 8.3%, with a 9% bounce off the daily 20-day moving average that opens a fresh Buy signal. Phio Pharmaceuticals stock still faces a real wall overhead — the 7-day high has already rejected the price four times — and the trigger only fires once that level breaks. Healthcare stocks are running hot right now, and that backs the turnaround case.
IQS Phase
49
ordinary
Signal Strength
76
high · wide & volatile
Sizing
FULL
Ranking
#9 / 14
New us stocks
Trade P&L %
+0.00%
from signal to date, no stop loss
Rank position
ranks 9th among the 14 fresh Longs for US stocks in our ranking, with a signal strength of 76 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
PHIO belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content